Duramune Cv-K

Canine Coronavirus Vaccine

Killed Virus

For use in animals only

This product has been shown to be effective for the vaccination of healthy dogs six weeks of age or older against disease caused by canine coronavirus. The duration of immunity for this product has not been established. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.

Dose: Dogs, inject one 1 mL dose subcutaneously or intramuscularly using aseptic technique. The presence of maternal antibody is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. All dogs should initially receive one dose and a second dose 2 to 3 weeks later. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended. This product has not been tested in pregnant animals.

Duramune Cv-K Caution

DO NOT USE AS DILUENT FOR LIVE VACCINES. Store in dark at 2° to 8°C (35° to 46°F). AVOID FREEZING. SHAKE WELL. Do not mix with other products except as specified on the label. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

Gentamicin, thimerosal and amphotericin B added as preservatives.

Duramune Cv-K Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Duramune, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2017 Elanco US Inc. all rights reserved.

Elanco US Inc., Fort Dodge, IA 50501

phone 888-545-5973

VLN/PCN 196/14P5.20

25 Doses

25 x 1 mL Vials of Vaccine

YL102102X

CPN: 1943003.1